Queensland-based Medibis has secured funding to pioneer a clinical trial aimed at alleviating anxiety symptoms associated with Autism Spectrum Disorder (ASD). Dr. Janet Schloss and Dr. Andrew Cashin will spearhead the study at Southern Cross University, exploring cannabis formulations as potential alternatives to traditional pharmaceuticals.
Althea Expands UK Presence with Vessel Hardware Distribution
Althea Group Holdings has entered a strategic partnership with Just Brands International, securing exclusive rights to distribute Vessel-branded hardware in the UK. This move targets the burgeoning medical cannabis market, focusing on dried flower and vape cartridge patients.
Elixinol’s Leadership Transition Marks New Era
Following the acquisition of Ananda Food, Elixinol Wellness Group bids farewell to CEO Ron Dufficy. The company is actively seeking a new leader to steer its expanded portfolio, emphasizing plant-based wellness products.
Ecofibre’s Ananda Food Acquisition
- Ecofibre has recently acquired Ananda Food, signaling a shift towards hemp food and animal products.
- The integration of Ananda Food is expected to diversify Elixinol’s offerings and reduce reliance on its CBD portfolio.
Aura Therapeutics’ Rebranding and Expansion
- Aura Therapeutics, formerly known as Endoca Australia, has launched a new dried flower range.
- The rebranding effort aligns with the company’s strategy to broaden its product offerings and cater to a wider market.
InhaleRx’s Commitment to Innovative Therapies
InhaleRx Ltd continues to lead in the development of inhaled therapies, targeting acute symptoms in mental health and pain management. The company’s approach promises rapid-onset treatments, addressing a significant market need.